GPT and metabolic dysfunction-associated steatotic liver disease: A secondary analysis of a multicenter randomized trial that included 178 children with biopsy‐proven NAFLD (TONIC trial) found that ALT was able to discriminate between those children that progressed from those that improved, based on a subsequent liver histology.107